financetom
Business
financetom
/
Business
/
Renasant to Acquire The First Bancshares for $1.2 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Renasant to Acquire The First Bancshares for $1.2 Billion
Jul 30, 2024 4:10 AM

06:55 AM EDT, 07/30/2024 (MT Newswires) -- Renasant ( RNST ) will acquire The First Bancshares (FBMS) in an all-stock deal worth roughly $1.2 billion, expanding its footprint in the US southeast.

Investors of The First will receive one share of Renasant ( RNST ) stock for each share owned, the lenders said in a joint statement late Monday. This implies a transaction value of about $37.09 per share of The First, based on Renasant's ( RNST ) closing price on Friday. All options of The First will be cashed out at their in-the-money value at the completion of the deal, according to the statement.

Shares of Renasant ( RNST ) declined 4.7% in premarket activity Tuesday, while The First rose 7.7%.

The deal, which will see The First merge into Renasant ( RNST ), is projected to create a six-state southeastern banking franchise with roughly $25 billion in assets, $18 billion in loans and $21 billion in deposits, according to the lenders. The merger requires approval from regulators and the banks' shareholders and is expected to close in the first half of next year.

"As with Renasant ( RNST ), The First has expanded into some of the most dynamic, fastest growing markets in the southeast," Renasant ( RNST ) Chief Executive Mitch Waycaster said in the joint statement. "Together, we create a more valuable company with the meaningful scale needed to compete in today's operating environment."

Excluding one-time transaction costs, the merger is estimated to be immediately accretive to Renasant ( RNST ) earnings per share. The First has 111 branches across Mississippi, Louisiana, Alabama, Florida and Georgia, and the deal is expected to expand Renasant's ( RNST ) locations, services and products, President Kevin Chapman said.

"RNST gains a quality franchise within its existing southeastern footprint and also gains presence in higher growth markets," Truist Vice President Brandon King said in a note. Still, he said the deal's pricing and common equity raise at $32 a share "dull the financial merits of this deal, in our view."

Renasant ( RNST ) said separately on Monday it raised $200 million in an equity offering of 6.25 million shares, with proceeds earmarked for acquisitions and investments. Underwriters have an option to buy another 937,500 shares, the firm said.

The First CEO Ray Cole will become a senior executive vice president and join the board of directors of Renasant ( RNST ) and its Renasant Bank unit. Renasant ( RNST ) also announced a $10.3 billion five-year community benefit plan to promote economic growth, access to financial services and inclusion in the lenders' combined footprint.

Price: 34.00, Change: -1.95, Percent Change: -5.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CompoSecure Shares Rise After Q4 Results Top Estimates
CompoSecure Shares Rise After Q4 Results Top Estimates
Mar 7, 2024
01:44 PM EST, 03/07/2024 (MT Newswires) -- CompoSecure ( CMPO ) shares jumped 30% in recent Thursday trading, a day after the company reported Q4 earnings and revenue that topped estimates by analysts. The company on Wednesday reported Q4 adjusted diluted earnings of $0.26 a share, up from $0.20 a year earlier. Analysts polled by Capital IQ expected $0.23. Revenue...
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Mar 7, 2024
Thursday, Alligator Bioscience AB and Aptevo Therapeutics Inc ( APVO ) released interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 for solid tumors likely to express the tumor antigen 5T4. The multi-center, dose-escalation trial is now more than 50% enrolled, and preliminary results include: Treatment was overall well-tolerated, and a maximum tolerated dose has not yet been determined. Dose...
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
Mar 7, 2024
LAGUNA BEACH, California (Reuters) -Rivian on Thursday unveiled its smaller and less expensive R2 SUVs and R3 crossovers amid a slowdown in demand for EVs and also said it would start producing the R2 at its existing facility in Illinois to ensure deliveries in 2026. Rivian shares were up 10% at $12.16 on Thursday afternoon. The R2, with a starting...
Albemarle Unusual Options Activity
Albemarle Unusual Options Activity
Mar 7, 2024
Investors with a lot of money to spend have taken a bullish stance on Albemarle . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALB,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved